Iht Wealth Management, LLC Inovio Pharmaceuticals, Inc. Transaction History

Iht Wealth Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 17, 2021	SELL	$8.5 - $12.85 $85,773 - $129,669	-10,091 Closed	0 $0
Q3 2020 Nov 19, 2020	BUY	$9.57 - $27.05 $96,570 - $272,961	10,091 New	10,091 $117,000
Q2 2020 Aug 14, 2020	SELL	$7.14 - $31.69 $74,684 - $331,477	-10,460 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$2.98 - $14.09 $31,170 - $147,381	10,460 New	10,460 $78,000
Q2 2019 Aug 12, 2019	SELL	$2.29 - $4.1 $41,348 - $74,029	-18,056 Closed	0 $0
Q1 2019 May 16, 2019	SELL	$3.34 - $5.1 $724 - $1,106	-217 Reduced 1.19%	18,056 $67,000
Q4 2018 Feb 15, 2019	BUY	$3.89 - $6.11 $7,780 - $12,220	2,000 Added 12.29%	18,273 $73,000
Q3 2018 Nov 14, 2018	BUY	$3.92 - $5.58 $4,312 - $6,138	1,100 Added 7.25%	16,273 $90,000
Q2 2018 Aug 13, 2018	SELL	$3.88 - $5.16 $4,462 - $5,934	-1,150 Reduced 7.05%	15,173 $59,000
Q1 2018 May 15, 2018	BUY	$4.05 - $5.69 $437 - $614	108 Added 0.67%	16,323 $72,000
Q4 2017 Feb 14, 2018	BUY	$4.13 - $6.68 $52,190 - $84,415	12,637 Added 353.19%	16,215 $70,000
Q3 2017 Nov 14, 2017	BUY	$5.36 - $6.37 $19,178 - $22,791	3,578	3,578 $23,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $559M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Iht Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Iht Wealth Management, LLC with notifications on news.